These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9006937

  • 1. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
    Kennedy K, Gigoux V, Escrieut C, Maigret B, Martinez J, Moroder L, Fréhel D, Gully D, Vaysse N, Fourmy D.
    J Biol Chem; 1997 Jan 31; 272(5):2920-6. PubMed ID: 9006937
    [Abstract] [Full Text] [Related]

  • 2. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.
    Escrieut C, Gigoux V, Archer E, Verrier S, Maigret B, Behrendt R, Moroder L, Bignon E, Silvente-Poirot S, Pradayrol L, Fourmy D.
    J Biol Chem; 2002 Mar 01; 277(9):7546-55. PubMed ID: 11724786
    [Abstract] [Full Text] [Related]

  • 3. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
    Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz JA, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy AD.
    Protein Sci; 1999 Nov 01; 8(11):2347-54. PubMed ID: 10595537
    [Abstract] [Full Text] [Related]

  • 4. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S, Hadjiivanova C, Escrieut C, Dufresne M, Martinez J, Vaysse N, Fourmy D.
    Eur J Biochem; 1993 Mar 01; 212(2):529-38. PubMed ID: 8444190
    [Abstract] [Full Text] [Related]

  • 5. Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin.
    Gigoux V, Escrieut C, Fehrentz JA, Poirot S, Maigret B, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy D.
    J Biol Chem; 1999 Jul 16; 274(29):20457-64. PubMed ID: 10400673
    [Abstract] [Full Text] [Related]

  • 6. A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin.
    Silvente-Poirot S, Wank SA.
    J Biol Chem; 1996 Jun 21; 271(25):14698-706. PubMed ID: 8663021
    [Abstract] [Full Text] [Related]

  • 7. Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state.
    Gigoux V, Escrieut C, Silvente-Poirot S, Maigret B, Gouilleux L, Fehrentz JA, Gully D, Moroder L, Vaysse N, Fourmy D.
    J Biol Chem; 1998 Jun 05; 273(23):14380-6. PubMed ID: 9603948
    [Abstract] [Full Text] [Related]

  • 8. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D.
    Mol Pharmacol; 1994 Apr 05; 45(4):599-607. PubMed ID: 8183238
    [Abstract] [Full Text] [Related]

  • 9. Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
    Bläker M, Ren Y, Gordon MC, Hsu JE, Beinborn M, Kopin AS.
    Mol Pharmacol; 1998 Nov 05; 54(5):857-63. PubMed ID: 9804620
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor.
    Silvente-Poirot S, Escrieut C, Galès C, Fehrentz JA, Escherich A, Wank SA, Martinez J, Moroder L, Maigret B, Bouisson M, Vaysse N, Fourmy D.
    J Biol Chem; 1999 Aug 13; 274(33):23191-7. PubMed ID: 10438490
    [Abstract] [Full Text] [Related]

  • 11. Conserved cholecystokinin receptor transmembrane domain IV amino acids confer peptide affinity.
    Ren Y, Bläker M, Seshadri L, McBride EW, Beinborn M, Kopin AS.
    J Mol Neurosci; 2003 Apr 13; 20(2):115-24. PubMed ID: 12794305
    [Abstract] [Full Text] [Related]

  • 12. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
    Stark HA, Sharp CM, Sutliff VE, Martinez J, Jensen RT, Gardner JD.
    Biochim Biophys Acta; 1989 Feb 09; 1010(2):145-50. PubMed ID: 2463851
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
    Amblard M, Rodriguez M, Lignon MF, Galas MC, Bernad N, Artis-Noël AM, Hauad L, Laur J, Califano JC, Aumelas A.
    J Med Chem; 1993 Oct 01; 36(20):3021-8. PubMed ID: 7692048
    [Abstract] [Full Text] [Related]

  • 14. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ.
    J Med Chem; 1996 Sep 27; 39(20):4120-4. PubMed ID: 8831778
    [Abstract] [Full Text] [Related]

  • 15. Full and partial agonist activity of C-terminal cholecystokinin peptides at the cloned human CCK-A receptor expressed in Chinese hamster ovary cells.
    Dunlop J, Zhang Y, Evans N.
    Peptides; 1997 Sep 27; 18(6):865-8. PubMed ID: 9285936
    [Abstract] [Full Text] [Related]

  • 16. Ligand-induced internalization of cholecystokinin receptors. Demonstration of the importance of the carboxyl terminus for ligand-induced internalization of the rat cholecystokinin type B receptor but not the type A receptor.
    Pohl M, Silvente-Poirot S, Pisegna JR, Tarasova NI, Wank SA.
    J Biol Chem; 1997 Jul 18; 272(29):18179-84. PubMed ID: 9218453
    [Abstract] [Full Text] [Related]

  • 17. CCK antagonists reveal that CCK-8 and JMV-180 interact with different sites on the rat pancreatic acinar cell CCKA receptor.
    Yule DI, Williams JA.
    Peptides; 1994 Jul 18; 15(6):1045-51. PubMed ID: 7527529
    [Abstract] [Full Text] [Related]

  • 18. The role of the cholecystokinin-B/gastrin receptor transmembrane domains in determining affinity for subtype-selective ligands.
    Kopin AS, McBride EW, Quinn SM, Kolakowski LF, Beinborn M.
    J Biol Chem; 1995 Mar 10; 270(10):5019-23. PubMed ID: 7890609
    [Abstract] [Full Text] [Related]

  • 19. Conformational and molecular modeling studies of sulfated cholecystokinin-15.
    Giragossian C, Stone S, Papini AM, Moroder L, Mierke DF.
    Biochem Biophys Res Commun; 2002 May 10; 293(3):1053-9. PubMed ID: 12051766
    [Abstract] [Full Text] [Related]

  • 20. Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors.
    Wang HL.
    J Neurochem; 1997 Apr 10; 68(4):1728-35. PubMed ID: 9084447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.